When is chemotherapy recommended for acute myeloid leukaemia?

Acute myeloid leukaemia can interfere with normal blood-cell production. The haematology team uses blood tests, bone-marrow examination, chromosome and gene findings, age, fitness and other illnesses to select treatment. Intensive chemotherapy may aim to achieve remission, followed by additional treatment to lower the risk of return. People who are not suited to intensive treatment may be offered a less intensive combination. Some subtypes need a specific medicine approach, and a transplant may be discussed when appropriate.

Ask which AML subtype is present and whether gene or chromosome findings change the recommended regimen. Discuss hospital stays, transfusions, infection prevention, fertility preservation and how response will be measured. Give the team a complete medicine list and mention dental problems, allergies or recent infections. Do not delay a planned admission or take new medicines without checking, because interactions and low blood counts can be serious.

Call the haematology team urgently for fever, shaking chills, new breathlessness, bleeding, black stools, severe mouth sores or worsening weakness. A low neutrophil count can make infection dangerous without a high fever. Emergency help is needed for severe breathing difficulty, confusion, a seizure, collapse or bleeding that will not stop.

What AML features determine my chemotherapy? Is intensive treatment suitable for me? What are the aims of each phase? Could targeted medicine or transplant be considered? Which symptoms require an immediate call?